• A
• A
• A

Smoking Cessation Reduces Risk of Head and Neck Cancer (11/03/2009)
Compared with people who continue to smoke, people who stop smoking have a 30% lower risk of head and neck cancer within one to four years of quitting, and a 77% lower risk after 20 years. Quitting alcohol also reduces the risk of head and neck cancer, but the benefit takes longer to become apparent. These results were published in the International Journal of Epidemiology.

Differences in HPV Rates May Contribute to Racial Differences in Head and Neck Cancer Survival (07/30/2009)
Among patients with head and neck cancer, the better survival among white patients than black patients appears to be due at least in part to the higher prevalence of HPV-related oropharyngeal cancer in white patients. These results were published in Cancer Prevention Research.

Oral Spray Reduces Mouth Sores (07/21/2009)
Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published in Cancer.

HPV-related Oropharyngeal Cancer Has Favorable Prognosis (05/20/2009)
According to the results of a study that will be presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), oropharyngeal cancer that results from human papillomavirus (HPV) infection appears to have a better prognosis than oropharyngeal cancer that is linked with other causes such as smoking.

Three-drug Combination Increases Rates of Larynx Preservation (03/30/2009)
Among patients with locally advanced cancer of the larynx or hypopharynx, induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (5-FU) resulted in higher rates of larynx preservation than induction chemotherapy with only cisplatin and 5-FU. These results were published in the Journal of the National Cancer Institute.

▪ More...

Smoking Cessation Reduces Risk of Head and Neck Cancer (11/03/2009)
Compared with people who continue to smoke, people who stop smoking have a 30% lower risk of head and neck cancer within one to four years of quitting, and a 77% lower risk after 20 years. Quitting alcohol also reduces the risk of head and neck cancer, but the benefit takes longer to become apparent. These results were published in the International Journal of Epidemiology.

Differences in HPV Rates May Contribute to Racial Differences in Head and Neck Cancer Survival (07/30/2009)
Among patients with head and neck cancer, the better survival among white patients than black patients appears to be due at least in part to the higher prevalence of HPV-related oropharyngeal cancer in white patients. These results were published in Cancer Prevention Research.

Oral Spray Reduces Mouth Sores (07/21/2009)
Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published in Cancer.

HPV-related Oropharyngeal Cancer Has Favorable Prognosis (05/20/2009)
According to the results of a study that will be presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), oropharyngeal cancer that results from human papillomavirus (HPV) infection appears to have a better prognosis than oropharyngeal cancer that is linked with other causes such as smoking.

Three-drug Combination Increases Rates of Larynx Preservation (03/30/2009)
Among patients with locally advanced cancer of the larynx or hypopharynx, induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (5-FU) resulted in higher rates of larynx preservation than induction chemotherapy with only cisplatin and 5-FU. These results were published in the Journal of the National Cancer Institute.

▪ More...